Workflow
湖南裕能(301358) - 2025年11月18日投资者关系活动记录表
2025-11-19 01:12
编号:2025-011 证券代码:301358 证券简称:湖南裕能 湖南裕能新能源电池材料股份有限公司 投资者关系活动记录表 | | □特定对象调研 □分析师会议 | | --- | --- | | | □媒体采访 □业绩说明会 | | 投资者关系活 | □新闻发布会 □路演活动 | | 动类别 | □现场参观 | | | ☑ 其他(电话会议) | | 参与单位名称 | 鹏华基金、太平资产、汇丰资管、花旗环球、东吴证券 | | 时间 | 2025 年 11 月 18 日 | | 地点 | 电话会议 | | 上市公司接待 | 董事、常务副总经理兼董事会秘书 汪咏梅 | | 人员姓名 | 证券事务代表 何美萱 | | | 1、请问公司认为本轮涨价的契机是什么?落地情况如何? | | | 回复:主要是基于两方面因素:一是公司产品处于供不应求的 | | | 状况,尤其新产品供需矛盾比较突出;二是部分原材料价格上涨带 | | | 来成本压力。公司与客户积极开展商务谈判,目前已取得了较好的 | | | 效果。 | | 投资者关系活 | 2、公司磷矿开采的进展如何?预计对利润有多少贡献? | | 动主要内容介 | 回复:自 ...
新时达(002527) - 2025年11月18日投资者关系活动记录表
2025-11-18 14:48
证券代码:002527 证券简称:新时达 上海新时达电气股份有限公司投资者关系活动记录表 编号:2025-011 | | 用需求。截至目前,新时达人形机器人已在海尔重庆冰箱工厂现场产线完成部 | | --- | --- | | | 署,并于真实场景中开展实训,后续将逐步承担作业并进阶复杂流程。 | | | 3、能否介绍一下公司生产的晶圆机器人? | | | 答:公司的晶圆机器人是公司通过长达三年持续研究之后,推出的国内领 | | | 先的半导体晶圆传输机器人,涵盖分别应用于大气环境和真空环境的 8 大系 | | | 列数十款不同型号的产品,能够覆盖热处理、清洗、刻蚀、薄膜、黄光、减薄、 | | | 键合等前/后道半导体工艺制程,实现了设备的国产化替代,并已批量应用于 | | | 生产模拟芯片、功率芯片、传感器芯片、LED 芯片等前道晶圆厂(FAB)。 | | | 4、公司的定增进度如何? | | | 答:截至目前,公司正持续推进本次向特定对象发行股票事项,后续尚需 | | | 经深圳证券交易所审核通过,并获中国证券监督管理委员会同意注册的决定 | | | 后方可实施。后续具体进展请以公司在指定信息披露媒体巨潮 ...
实丰文化(002862) - 002862实丰文化投资者关系管理信息20251118
2025-11-18 14:32
证券代码: 002862 证券简称:实丰文化 实丰文化发展股份有限公司投资者关系活动记录表 编号:2025006 投资者关系活动 类别 特定对象调研 □ 分析师会议 □ 媒体采访 □ 业绩说明会 □ 新闻发布会 □ 路演活动 □ 现场参观 □其他 参与单位名称及 人员姓名 西南证券 苟宇睿 平安基金 杨博茜 金鹰基金 谭亚兰 前海开源基金 夏英妍 传奇投资 姚天航 时间 2025 年 11 月 18 日(周二)15:00-17:00 地点 广东省汕头市澄海区澄华工业区实丰文化发展股份有限公司 上市公司接待人 员姓名 1、董事、董事会秘书:王依娜女士 2、AI 玩具负责人:时杰先生 3、研发设计部负责人:纪一桀先生 投资者关系活动 主要内容介绍 一、公司董事会秘书王依娜女士对公司发展历程作了介绍。 二、提问主要内容如下: (一)公司目前在手 IP 有哪些? 答:公司已构建起覆盖多领域的多元 IP 矩阵——从国际顶 流 IP 宝可梦、迪士尼(冰雪奇缘、玩具总动员、疯狂动物城、 怪兽大学等),国际动漫 IP 海绵宝宝,到手游 IP 蛋仔派对, 再到国民动画 IP 超级飞侠、熊熊乐园、喜羊羊与灰太狼,爆款 表情包 I ...
广发证券(000776) - 2025年11月18日投资者关系活动记录表
2025-11-18 13:00
证券代码:000776 证券简称:广发证券 1 | 2、公司投资银行业务的发展情况? | | --- | | 答:公司立足服务实体经济高质量发展,深入贯彻国家 | | 战略与监管要求,积极发挥直接融资"服务商"及资本市场 | | "看门人"功能。坚持行业引领,加强重点赛道产业资源积 | | 累与专业能力建设,着力打造产业投行、科技投行。深耕重 | | 点区域,巩固大湾区市场地位及竞争力,深化长三角重点区 | | 域布局。持续深化境内外一体化战略,健全跨境人才培养及 | | 协同机制,全面提升跨境协作质效和综合服务能力,有效助 | | 力中国企业出海布局。扎实推进数智化转型,强化精细化管 | | 理和风险防控,不断夯实提质增效、稳健发展的基础。 | | 3、公司场外衍生品业务的发展情况? | | 答:公司作为场外衍生品业务一级交易商,立足衍生品 | | 定价和交易的专业优势,持续强化团队及系统建设,深耕产 | | 品创设、策略创新、交易销售及客户服务能力,丰富和拓展 | | 产品体系、挂钩标的种类及收益结构,持续为机构客户提供 | | 以场外衍生品为载体的资产配置和风险管理解决方案。 | | 4、公司投资管理业 ...
九典制药(300705) - 300705九典制药投资者关系管理信息20251118
2025-11-18 11:36
Group 1: Product Performance and Market Strategy - The company’s Loxoprofen Sodium Gel Patch was selected in the 11th batch of national drug centralized procurement with prices set at ¥17.88 for 4 patches, ¥26.82 for 6 patches, and ¥35.76 for 8 patches, with a planned selection quantity of 30.122605 million patches [2] - The company anticipates a certain growth in sales for the Loxoprofen Sodium Gel Patch post-price reduction due to the ongoing growth in the chronic pain treatment market, with actual performance feedback expected after next year's procurement execution [2][3] - The company plans to expand its sales channels and enhance brand building in response to the centralized procurement, leveraging its established multi-channel coverage system [4] Group 2: Financial Impact and Adjustments - The centralized procurement is expected to lead to a phase adjustment in profit margins for the Loxoprofen Sodium Gel Patch, impacting short-term revenue and profit performance [3] - The company is facing pressure to meet its annual targets due to market challenges, prompting a focus on promoting new products and enhancing market penetration through education and optimized product positioning [9] Group 3: Innovation and R&D Initiatives - The company is transitioning towards innovative drug development, establishing multiple R&D centers and focusing on various drug forms and collaboration models [5] - The R&D team consists of over 40 experts with experience in drug design and clinical research, focusing on oncology and chronic disease treatments using small molecules, peptides, and other drug forms [5] - The JIJ02 gel is expected to complete Phase I clinical trials in the first half of next year, with Phase II trials to follow [6] Group 4: Corporate Governance and Employee Engagement - The company is implementing a share repurchase plan to support future equity incentive programs, aiming to align the interests of the company, shareholders, and core team members [7]
富特科技(301607) - 2025年11月18日投资者关系活动记录表
2025-11-18 11:24
Group 1: Customer Position and Market Strategy - The company has established stable partnerships with leading domestic automakers such as GAC, NIO, Great Wall, Xiaomi, Xpeng, and others, positioning itself as a core supplier in their supply chains [1] - The company has not received specific annual reduction requests from clients for the upcoming year but is preparing for potential reductions by optimizing production processes and enhancing bargaining power [1][2] Group 2: Overseas Business Development - In 2024, the company began bulk supply of overseas projects, achieving approximately 6.8% revenue from exports in the first year [3] - By the first half of 2025, the revenue share from overseas projects exceeded 17%, marking a significant step in international expansion [3] - The company faces competition from global suppliers like Bosch, Valeo, and Continental but believes its domestic market experience and rapid response capabilities provide a competitive edge [4] Group 3: Production Capacity and Efficiency - The core production bases are the Anji Plant 1 and Plant 2, with Plant 1 having a designed capacity of 1.2 million units and currently operating at full capacity [5] - Plant 2 was successfully launched earlier this year, with ongoing efforts to enhance production capacity through technological upgrades and process optimization [5] - The company emphasizes asset efficiency to avoid resource idleness while integrating smart logistics and warehousing into its long-term development plans [5] Group 4: Future Outlook and Innovations - The company is optimistic about the growth of its overseas market share, expecting a steady increase based on current project developments [6] - Progress has been made in the overseas V2G (Vehicle-to-Grid) business, with products under development that support bidirectional charging, which is seen as crucial for stabilizing and optimizing overseas power grids [7]
山大电力(301609) - 301609山大电力投资者关系管理信息20251118
2025-11-18 11:12
Company Overview - Shandong University Power Technology Co., Ltd. focuses on power monitoring and has a strategic plan aligned with the national energy transition goals [1]. - The company’s products are primarily utilized in the power grid sector, with approximately 90% of revenue derived from substation and transmission products [2]. Market Opportunities - The "14th Five-Year Plan" period marks a transition towards better electricity usage and green energy, while the "15th Five-Year Plan" is critical for achieving carbon peak goals, presenting significant market opportunities for the power monitoring industry [1]. - The investment in smart and digital technologies by State Grid and Southern Grid is expected to enhance the demand for power monitoring equipment [1]. Competitive Landscape - Key competitors include Wuhan Zhongyuan Huadian Technology Co., Ltd., Shandong Kehui Power Automation Co., Ltd., and others in specific segments [2]. - The company maintains a competitive edge through continuous innovation in R&D, ensuring products meet market demands [3]. Customer Base and Service - The company has established long-term relationships with major clients such as State Grid and Southern Grid, which underscores the reliability and quality of its products [3]. - A nationwide service network with 17 contact offices enables rapid local support, enhancing customer satisfaction [4]. New Energy and Storage Business - Future plans for the new energy sector focus on integrated solutions for energy storage and charging stations, with a stable order backlog supporting growth [5][6]. - The energy storage business targets large-scale enterprises and aims to develop products that meet the requirements of the new power system [6]. Financial Outlook - The company anticipates stable order conditions across its two main business segments: power monitoring and new energy, providing a solid foundation for future growth [6]. - The management is optimistic about future performance, with strategic planning in place to drive business expansion [6].
汤臣倍健(300146) - 2025年11月18日投资者关系活动记录表
2025-11-18 11:08
证券代码:300146 证券简称:汤臣倍健 | | □分析师会议 特定对象调研 | | --- | --- | | 投资者关系活动 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | 类别 | □现场参观 | | | □其他 | | 参与单位名称及 | 详见附件 | | 人员姓名 | | | 时间 | 年 月 日 2025 11 18 15:00-16:30 | | 地点 | 广东省广州市黄埔区鱼珠街道黄埔大道东 号 916 | | 上市公司接待人 | 公司董事会秘书唐金银女士 | | 员姓名 | | | | 会议采取互动问答形式,主要沟通内容如下: | | | Q:公司后续组织架构及人员上是否会变化来匹配未来的发展需求 | | | 过去两年公司对组织架构进行了一系列调整,确立了品牌事业部从产 | | | 品研发、市场推广到销售落地的全周期管理机制,后续架构优化更加侧重 | | | 在业务赋能上,整体来看不会有大的变动。 | | | Q:公司未来在线上及线下的发展策略 | | 投资者关系活动 | 线上方面,抖音为 VDS 行业线上销售的第一大平台且持续保持高速增 | | 主要内容介绍 ...
艾比森(300389) - 2025年11月18日投资者关系活动记录表
2025-11-18 10:56
Group 1: Company Performance and Strategy - The company achieved significant growth in the first half of 2025, with a positive growth trend expected to continue into Q3 2025 due to international market penetration and localized operations [2][3]. - Absen focuses on maintaining technological leadership by investing in cutting-edge technologies such as Micro LED and virtual production, ensuring sustained commercial competitiveness [3][4]. - The company has redefined its brand positioning from "LED display application and service provider" to "global leader in LED display technology and applications," reflecting a commitment to industry leadership and customer service [4]. Group 2: Business Operations and Product Offerings - Absen is a leading global provider of LED display products, offering a full range of solutions from outdoor to indoor applications, with a diverse product line including advertising, stage, and smart screens [5]. - The company has made progress in its energy storage business, providing safe and sustainable products and services across Europe, Asia-Pacific, and domestic markets [5][6]. - Absen has successfully developed LED virtual studios, addressing key technical challenges and achieving positive market feedback with numerous landmark projects globally [6]. Group 3: Core Competencies - The company maintains a competitive edge through six core competencies: technological leadership, brand influence, service excellence, cost competitiveness, extensive sales network, and organizational culture [6][7]. - Absen has built a robust service system that supports customers throughout the entire lifecycle of the product, enhancing customer satisfaction and loyalty [6]. Group 4: Employee Incentives and Governance - The company has implemented three employee stock ownership plans (ESOPs) for 2022, 2023, and 2025, with incentive funds of 50 million, 40 million, and 60 million yuan respectively, aimed at aligning employee interests with company performance [8]. - These ESOPs are designed to improve corporate governance, enhance employee engagement, and attract and retain top talent, thereby supporting long-term strategic development [8].
华兰股份(301093) - 2025年11月18日投资者关系活动记录表
2025-11-18 10:50
Group 1: Company Overview and Strategic Moves - Jiangsu Hualan Pharmaceutical New Materials Co., Ltd. has over 1,000 pharmaceutical clients across more than 40 countries, providing a market entry and customer connection channel for its subsidiary, Kema Biotechnology [2] - The company is entering the AI innovative drug research and development field, responding to the global trend where major pharmaceutical companies are integrating AI into their strategic core [2] - The investment in Kema Biotechnology is seen as the first step in the company's strategic layout in AI innovative drug R&D, aiming to enhance technical service capabilities and foster new growth curves [2] Group 2: Product Development and Regulatory Status - The transition of the pen-type injector aluminum cap to "A" status allows the company to provide an integrated supply capability for core components of pen-type injectors, enhancing its competitive edge [3] - This transition also establishes a self-controlled supply chain for high-end pharmaceutical packaging materials, which have historically been dominated by international companies [3] - The company aims to meet the growing demand for high-end pen-type injector packaging materials, positively impacting future operational performance [3] Group 3: Collaboration and Market Expansion - The collaboration with Ganli Pharmaceutical Co., Ltd. is progressing well, with the recent regulatory approval strengthening this partnership [3] - The company is actively expanding its customer base, with positive developments reported in this area [3] Group 4: Shareholder Confidence and Future Outlook - The controlling shareholder's intention to increase shareholding reflects confidence in the company's long-term investment value and stable future development [4] - The company will disclose its full-year performance for 2025 in its annual report, which will be available on the designated information platform [4]